AI assistant
Citadel Group M&A Activity 2020
10454_mrq_2020-10-05_bbda98c7-87ac-4b8f-a097-78f95c670f45.html
M&A Activity
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 1042B
Citadel Group
05 October 2020
Ap 19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Citadel Group |
| Company dealt in | WILLIS TOWERS WATSON PLC |
| Class of relevant security to which the dealings being disclosed relate (Note 2) | Common Stock ISIN IE00BDB6Q211 |
| Date of dealing | 02 October, 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security
dealt in (Note 3)
| Long | Short | |
| ISIN IE00BDB6Q211 | Number (%) | Number (%) |
| (1) Relevant securities | 488,513 (0.38%) | 1,726 (0.00%) |
| (2) Derivatives (other than options) | 1,638,427 (1.27%) | 0 (0.00%) |
| (3) Options and agreements to purchase/sell | 0 (0.00%) | 0 (0.00%) |
| Total | 2,126,940 (1.65%) | 1,726 (0.00%) |
Ap 20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale ISIN IE00BDB6Q211 |
Number of securities | Price per unit (Note 5) |
| Buy Transaction | 191 | 209.2538 USD |
| Buy Transaction | 100 | 209.3300 USD |
| Buy Transaction | 23 | 209.3665 USD |
| Buy Transaction | 101 | 209.5618 USD |
| Buy Transaction | 1,619 | 209.6100 USD |
| Buy Transaction | 1,322 | 209.7993 USD |
| Buy Transaction | 234 | 209.9368 USD |
| Buy Transaction | 53 | 210.1475 USD |
| Buy Transaction | 395 | 210.1821 USD |
| Buy Transaction | 57 | 210.7300 USD |
| Buy Transaction | 200 | 211.1500 USD |
| Buy Transaction | 184 | 211.2300 USD |
| DVP Transaction | 2 | 209.6100 USD |
| RVP Transaction | 2 | 209.6100 USD |
| Sell Transaction | 89 | 209.0400 USD |
| Sell Transaction | 74 | 209.3268 USD |
| Sell Transaction | 109 | 209.3272 USD |
| Sell Transaction | 100 | 209.3950 USD |
| Sell Transaction | 100 | 209.4000 USD |
| Sell Transaction | 40 | 209.4415 USD |
| Sell Transaction | 1,130 | 209.4877 USD |
| Sell Transaction | 1,567 | 209.4877 USD |
| Sell Transaction | 390 | 209.6100 USD |
| Sell Transaction | 59 | 209.6700 USD |
| Sell Transaction | 300 | 209.6800 USD |
| Sell Transaction | 10 | 210.1500 USD |
| Sell Transaction | 6,408 | 210.3475 USD |
| Sell Transaction | 8,992 | 210.3499 USD |
| Sell Transaction | 561 | 210.5557 USD |
| Sell Transaction | 6 | 210.8600 USD |
| Sell Transaction | 641 | 210.9017 USD |
| Sell Transaction | 2 | 211.6700 USD |
| Sell Transaction | 45 | 211.8089 USD |
| Sell Transaction | 16 | 211.8400 USD |
(b) Derivatives transactions (other than options transactions)
| Product name, e.g. CFD ISIN IE00BDB6Q211 |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (Note 5) |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
| Product name, e.g. call option | Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. |
Expiry date | Option money paid/ received per unit (Note 5) |
(ii) Exercising
| Product name, e.g. call option |
Number of securities | Exercise price per unit (Note 5) |
(d) Other dealings (including transactions in respect of new securities) (Note 4)
| Nature of transaction (Note 8) |
Details | Price per unit (if applicable) (Note 5) |
Ap 21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
| Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated |
| None |
Is a Supplemental Form 8 attached? (Note 9)
NO
| Date of disclosure: | 05 October, 2020 |
| Contact name: | Kim Heslop |
| Telephone number: | 020 7645 9700 |
| If a connected EFM, name of offeree/offeror with which connected | n/a |
| If a connected EFM, state nature of connection (Note 10) | n/a |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ISEEANESESDEFEA